News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
no_data1Bitget UEX Daily | Trump Plans to Declare Iran War Victory Closure; SpaceX Secret IPO; Storage and Optical Communication Strong Rebound (April 2, 2026)2SpaceX's $75B Public Offering: Unprecedented Liquidity Surge at 100 Times Revenue3UBS warns: Yen may fall to 175, intervention will only "drain foreign exchange reserves without turning the tide"
Flash
20:22
According to the latest filing with the U.S. Securities and Exchange Commission (SEC), the capital management company held a 14.6% passive stake in Townsquare Media (TSQ) as of March 31.This shareholding ratio highlights the investment institution’s significant interest in Townsquare Media.
20:22
Esperion Therapeutics Inc. (ESPR) has entered into a new financial arrangement with the Athyrium Fund.According to the terms of the agreement, the Athyrium Fund will have the right to receive tiered royalties based on Esperion's net sales, with rates ranging from 12% to 33%. In addition, the Athyrium Fund will also be eligible for a series of milestone payments. These financial benefits will continue to accrue until the Athyrium Fund achieves a total return equal to 2.0 times its initial investment.
20:22
Athyrium Capital Management and Esperion Therapeutics Inc. (NASDAQ: ESPR) have signed a Japanese royalty financing agreement worth $50 millionThis financing aims to provide funding support for Esperion Therapeutics' strategic acquisition of Corstasis Therapeutics.
News